Genotypic drug-resistance prediction for MTBC is rapidly becoming more favoured than phenotypic drug-susceptibility testing due to its comparative speed and reliability 1 and has been endorsed by the ...
This paper provides a comprehensive analysis of linear regression models, focusing on addressing multicollinearity challenges in breast cancer patient data. Linear regression methodologies, including ...